Antisense oligonucleotides against HSV 1, and their preparation

Details Antisense oligonucleotides against HSV 1, and their preparation Antisense oligonucleotides against HSV 1, and their preparation

1994-07-27

1996-10-08

LeGuyader, John L.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

435 6, 435 9133, 4351721, 4351723, 4352402, 536 231, 536 245, 514 44, C12P 1934, C12Q 168, A61K 3170

Patent

active

055630502

ABSTRACT:
The invention relates to novel antisense oligonucleotides having the sequences ##STR1## and their mixtures, homologs or modified forms, against HSV 1.

REFERENCES:
patent: 5138045 (1992-08-01), Cook et al.
patent: 5248670 (1993-09-01), Arapes et al.
Sanbrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed. CSHL Press, NY 1989, p. 11.4.
McGeoch et al. J. Gen. Vir. 69:1531-1574, 1988.
Stein et al. Science 261:1004-1012 (1993).
Kole et al. Adv. Drug Der. Revs. 6:271 (1991).
McGraw et al. BioTechniques 8:674 (1990).
Eugen Uhlmann et al., "Antisense Oligonucleotides: A New Therapeutic Principle," Chemical Reviews, 90 (4): 544-584 (1990).
John F. Milligan et al., "Current Concepts in Antisense Drug Design," Journal of Medicinal Chemistry, 36(14): 1923-1937 (1993).
Wen-Yi Gao et al., "Mechanisms of Inhibition of Herpes Simplex Virus Type 2 Growth by 28-mer Phosphorothioate Oligodeoxycytidine," Journal of Biological Chemistry, 265(33): 20172-20178 (1990).
M. Kulka et al., "Site Specificity of the Inhibitory Effects of Oligo(nucleoside methylphosphonate)s Complementary to the Acceptor Splice Junction of Herpes Simplex Virus Type 1 Immediate Early mRNA 4," Proc. Nat'l Acad. Sci. USA, 86: 6868-6872 (1989).
P. Dan Cook, "Medicinal Chemistry of Antisense Oligonucleotides--Future Opportunities," Anti-Cancer Drug Design, 6: 585-607 (1991).
John Goodchild, "Conjugates of Oligonucleotides and Modified Oligonucleotides: A Review of Their Synthesis and Properties," Bioconjugate Chemistry, 1(3): 165-187 (1990).
Serge L. Beaucage et al., "The Synthesis of Modified Oligonucleotides by the Phosphoramidite Approach and Their Applications," Tetrahedron Report No. 335, 49(28): 6123-6194 (1993).
F. Eckstein (ed.), "Olgonucleotides and Analogues--A Practical Approach," IRL Press at Oxford University Press, pp. ix-xxi.
Eugene P. Stirchak et al., "Uncharged Stereoregular Nucleic Acid Analogs: 2. Morpholino Nucleoside Obligomers with Carbamate Internucleoside Linkages," Nucleic Acids Research, 17(15): 6129-6141 (1989).
Jeffery C. Hanvey et al., "Antisense and Antigene Properties of Peptide Nucleic Acids," Science, 258: 1481-1485 (1992).
Masakazu Koga et al., "Alternating .alpha.,.beta.-Oligothymidylates with Alternating(3'--3')-and (5'--5')-Internucleotidic Phosphodiester Linkages as Models for Antisense Oligodeoxyribonucleotides," The Journal of Organic Chemistry, 56(12): 3757-3759 (1991).
M. Sawadogo et al., "A Rapid Method for the Purification of Deprotected Oligodeoxynucleotides," Nucleic Acids Research, 19(3): 674 (1991).
Jeffry S. Mann et al., "Synthesis and Properties of an Oligodeoxynucleotide Modified with a Pyrene Derivative at the 5'-Phosphate," Bioconjugate Chem., 3: 554-558 (1992).
F. Schubert et al., "One-step Labelling of Oligonucleotides with Fluoresceine during Automated Synthesis," Nucleic Acids Research, 18(11): 3427 (1990).
Glenn D. Hoke et al., "Effects of Phosphorothioate Capping on Antisense Oligonucleotide Stability, Hybridization and Antiviral Efficacy Versus Herpes Simplex Virus Infection," Nucleic Acids Research, 19(20): 5743-5748 (1991).

Affiliated with

Also associated with

Rating

Antisense oligonucleotides against HSV 1, and their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotides against HSV 1, and their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides against HSV 1, and their preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-56324